Name | RINALMED, OOO |
|---|
INN | 7813369485 |
|---|
KPP | 781301001 |
|---|
OGRN | 1077847021383 |
|---|
OKPO | 98616922 |
|---|
Address | 197198, G.sankt-peterburg, pr-kt Bol'shoy P.s., d. D. 18, of. POMESCH. 15-N(19) |
|---|
Phone | 956-41-45 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 33.13 | Additional activity | Repair of electronic and optical equipment | | 46.76 | Additional activity | Wholesale trade of other intermediate products |
Registration date | 16.02.2007 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N15 po Sankt-Peterburgu |
|---|
|
RINALMED, OOO (Saint Petersburg; INN 7813369485) was registered on 16 Feb 2007. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of RINALMED, OOO - Limited liability companies. Form of ownership of RINALMED, OOO - Private property. Principal activities of RINALMED, OOO: wholesale of pharmaceutical goods (46.46), repair of electronic and optical equipment (33.13), wholesale trade of other intermediate products (46.76). |
Economic indicators2023
Net profit (RAS) of RINALMED, OOO grew over 2023 by 15.70% to 13.15 million RUB from 11.36 million RUB over 2022, the company informed. Revenue increased in the accounting period by 48.63% to 179.78 million RUB from 120.96 million RUB over 2022. 2022
Net profit (RAS) of RINALMED, OOO dropped in 2022 by 21.66% to 11.36 million RUB from 14.50 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 22.19% to 120.96 million RUB from 155.45 million RUB in 2021. 2021
Net profit (RAS) of RINALMED, OOO grew over 2021 5.80 times to 14.50 million RUB from 2.50 million RUB over 2020, the company informed. Revenue increased in the accounting period 1.56 times to 155.45 million RUB from 99.59 million RUB over 2020. 2020
Net profit (RAS) of RINALMED, OOO dropped in 2020 9.38 times to 2.50 million RUB from 23.44 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 47.80% to 99.59 million RUB from 190.76 million RUB in 2019; cost of goods sold decreased 2.06 times to 69.72 million RUB from 143.87 million RUB; sales profit fell 3.68 times to 5.62 million RUB from 20.66 million RUB. 2019
Net profit (RAS) of RINALMED, OOO grew over 2019 2.20 times to 23.44 million RUB from 10.66 million RUB over 2018, the company informed. Revenue decreased in the accounting period by 2.35% to 190.76 million RUB from 195.34 million RUB in 2018; cost of goods sold grew by 1.22% to 143.87 million RUB from 142.13 million RUB; sales profit fell by 12.65% to 20.66 million RUB from 23.65 million RUB. 2018
Net profit (RAS) of RINALMED, OOO dropped in 2018 by 48.23% to 10.66 million RUB from 20.59 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 19.11% to 195.34 million RUB from 164.01 million RUB over 2017; cost of goods sold grew by 39.33% to 142.13 million RUB from 102.01 million RUB; sales profit fell by 27.77% to 23.65 million RUB from 32.74 million RUB. 2017
Net profit (RAS) of RINALMED, OOO grew over 2017 by 12.80% to 20.59 million RUB from 18.25 million RUB over 2016, the company informed. Revenue increased in the accounting period by 18.90% to 164.01 million RUB from 137.94 million RUB over 2016; cost of goods sold grew by 7.26% to 102.01 million RUB from 95.10 million RUB; sales profit went up 2.29 times to 32.74 million RUB from 14.32 million RUB. 2016
Net profit (RAS) of RINALMED, OOO grew over 2016 12.68 times to 18.25 million RUB from 1.44 million RUB over 2015, the company informed. Revenue increased in the accounting period by 35.36% to 137.94 million RUB from 101.90 million RUB over 2015; cost of goods sold grew by 44.82% to 95.10 million RUB from 65.67 million RUB; sales profit matched the previous year’s result amounting to 14.32 million RUB. 2014
Net profit (RAS) of RINALMED, OOO dropped in 2014 2.78 times to 3.97 million RUB from 11.05 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 1.21% to 75.31 million RUB from 74.41 million RUB over 2013; cost of goods sold grew by 7.48% to 42.13 million RUB from 39.20 million RUB; sales profit fell by 8.17% to 14.43 million RUB from 15.71 million RUB. 2013
Net profit (RAS) of RINALMED, OOO grew over 2013 by 42.73% to 11.05 million RUB from 7.74 million RUB over 2012, the company informed. Revenue increased in the accounting period by 41.19% to 74.41 million RUB from 52.70 million RUB over 2012; cost of goods sold grew 1.56 times to 39.20 million RUB from 25.05 million RUB; sales profit went up 1.53 times to 15.71 million RUB from 10.25 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|